Daiichi Sankyo Company Limited (D4S MU) stock market data APIs
€15.9581
0(0%)
as of February 5, 2026
Try our APIs with
free plan!
Daiichi Sankyo Company Limited Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for D4S.MU.
Prev. Close
15.9581
Open
15.9581
High
15.9581
Low
15.9581
52 wk Range
15.56-23.7283
Market Cap
38 045 M
Dividends (Yield)
0.5932
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Daiichi Sankyo Company Limited data using free add-ons & libraries
Get Daiichi Sankyo Company Limited Fundamental Data
Daiichi Sankyo Company Limited Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-01-30
- EPS/Forecast: 30.29
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Daiichi Sankyo Company Limited News
New
Asian Market Value Picks: Nanjing Leads Biolabs And 2 More Stocks Trading Below Estimated Worth
In recent weeks, the Asian markets have shown mixed performance, with China's CSI 300 Index remaining relatively stable and Hong Kong's Hang Seng Index experiencing notable gains. As investors navigat...
3 Asian Stocks Estimated To Be Trading At Up To 49.1% Below Intrinsic Value
As global markets navigate a landscape of steady interest rates and mixed economic signals, Asian stock markets are catching the attention of investors. In this environment, identifying undervalued st...
February 2026's Global Stocks Trading Below Estimated Value
As global markets navigate a landscape marked by steady interest rates and shifting consumer confidence, investors are increasingly focused on identifying opportunities amidst the volatility. With lar...
FDA Rejects AZN's Saphnelo SubQ Formulation, Priority Tag to Datroway
AstraZeneca AZN and its Japan-based partner Daiichi Sankyo announced that the FDA has accepted and granted priority review to their supplemental biologics license application (sBLA) seeking approval o...
Get Daiichi Sankyo Company Limited fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
